Home / Managing Editor, Diabetes in Control (page 29)

Managing Editor, Diabetes in Control

Recommending an SGLT-2

Do you feel comfortable recommending an SGLT-2 Inhibitor drug to your patients? Follow the link to share your opinion and see what others think!

Read More »

Question 835

Test Your Knowledge

Mr. Fontello is an overweight, Caucasian 63-year old patient who comes in for a 6-month check-up. He has a 12-year history of type 2 diabetes. He was diagnosed at age 33 with high blood pressure, but had never really done much about it as it was “too much of a hassle” and he felt “just fine.” At the time his diabetes was diagnosed, he was referred to a diabetes education program and was started on metformin, lovastatin, losartan and aspirin. He has an individualized A1C goal of 7%. Four years after diagnosis, pioglitazone was added to Mr. Fontello’s diabetes regimen. Three years ago, he came in for an appointment complaining of polyuria, polydipsia and fatigue with an office A1C of 9.3%. At that time he was started nightly basal insulin detemir. Since that time, he has made concerted efforts to eat a healthy diet and get to the gym. Today, he reports his SBGM fasting plasma glucose levels are on target (FPG below 130mg/dL). He also states that his feet always feel a little bit swollen. BP 128/78, HR 73, RR 19. Physical exam is remarkable for peripheral edema and mildly decreased pedal pulses. Current medications: metformin, pioglitazone, insulin detemir, lovastatin, losartan, aspirin. At today’s visit, his office A1C is 8.1%. What changes would you recommend for his antihyperglycemic regimen? Select one answer: [A] Add a premixed insulin to all three meals of the day [B] Increase his detemir dose [C] Add a sulfonylurea to his regimen [D] Add a rapid-acting insulin analogue to his largest meal of the day Are you right? Follow the link to find out!

Read More »